-

Product Pipeline Analysis on Huntleigh Healthcare Ltd - 2019 Update - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Huntleigh Healthcare Ltd - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Huntleigh Healthcare Ltd (Huntleigh Healthcare) is a medical device company. The company develops, manufactures and distributes electronic medical equipment. It offers vascular assessment and treatment; fetal and patient monitoring; and accessories and consumables.

Huntleigh Healthcare's vascular assessment and treatment products comprise dopplers and kits, high sensitivity probes, Dopplex intraoperative probe, dopplex ability ABI system, and documentation and reporting. The company's accessories and consumables include dopplex accessories and consumables; hydroven accessories and consumables; smartsigns accessories and consumables; and sonicaid accessories and consumables. It markets products through its distribution network across the UK. Huntleigh Healthcare is headquartered in Cardiff, the UK.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Huntleigh Healthcare Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Key Topics Covered:

  • Huntleigh Healthcare Ltd Company Overview
  • Huntleigh Healthcare Ltd Company Snapshot
  • Huntleigh Healthcare Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Huntleigh Healthcare Ltd - Pipeline Analysis Overview
  • Huntleigh Healthcare Ltd - Key Facts
  • Huntleigh Healthcare Ltd - Major Products and Services
  • Huntleigh Healthcare Ltd Pipeline Products by Development Stage
  • Huntleigh Healthcare Ltd Pipeline Products Overview
  • Dopplex ABI Ankle Brachial Index Kit
  • Dopplex ABI Ankle Brachial Index Kit Product Overview
  • Dopplex ATP Ankle & Toe Pressure Kit
  • Dopplex ATP Ankle & Toe Pressure Kit Product Overview
  • Dopplex DMX Digital Doppler With Waveform
  • Dopplex DMX Digital Doppler With Waveform Product Overview
  • LifePulse 110 R Wave Synchronisation Monitor
  • LifePulse 110 R Wave Synchronisation Monitor Product Overview
  • Smartsigns Compact 1200 Patient Monitor 12
  • Smartsigns Compact 1200 Patient Monitor 12 Product Overview
  • Smartsigns Compact 1500 Patient Monitor 15
  • Smartsigns Compact 1500 Patient Monitor 15 Product Overview
  • Smartsigns Compact 300 Monitor
  • Smartsigns Compact 300 Monitor Product Overview
  • Sonicaid Digital SR2 Doppler
  • Sonicaid Digital SR2 Doppler Product Overview
  • Sonicaid Digital SR3 Doppler
  • Sonicaid Digital SR3 Doppler Product Overview
  • Sonicaid SRX Digital Doppler
  • Sonicaid SRX Digital Doppler Product Overview
  • Sonicaid Team 3 Series Fetal/Maternal Monitor
  • Sonicaid Team 3 Series Fetal/Maternal Monitor Product Overview
  • Huntleigh Healthcare Ltd - Key Competitors
  • Huntleigh Healthcare Ltd - Key Employees
  • Huntleigh Healthcare Ltd - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • Huntleigh Healthcare Ltd, Recent Developments
  • Aug 30, 2019: Huntleigh launches advanced treatment device for lower limb wound healing
  • Jun 13, 2018: Huntleigh Healthcare selects MDI Solutions for Interface Engine Software
  • Jul 14, 2011: OSI Systems Launches High Performance Sonicaid Encore Fetal Monitor
  • Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer

For more information about this company profile visit https://www.researchandmarkets.com/r/scbb6m

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Poland Investment Funds and Asset Management Market Report 2026, Profiles of TFI, Pekao, Santander, PKO, Allianz, Goldman Sachs - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investment Funds and Asset Management Market in Poland, 2024-2026" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive overview of the investment funds and asset management sector in Poland. Analysis covers the main pillars of the market, including: mutual funds, insurance, and pension assets. The report also mid-term forecast of key volumes for the period 2025-2027. The data has been presented in a form of horizontal pr...

Europe Data Center Colocation Market Outlook & Forecast Report 2025-2030 Featuring Major Players - Digital Realty, Equinix, NTT DATA, Global Switch, CyrusOne, Ark Data Centres - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Data Center Colocation Market - Industry Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Europe Data Center Colocation Market was valued at USD 9.45 Billion in 2024, and is projected to reach USD 35.73 Billion by 2030, rising at a CAGR of 24.82%. The Europe data center colocation market is expected to witness cumulative investments of approximately $144.03 billion, of which, the Western Europe is slated to ac...

GCC Construction Equipment Market Research Report 2025-2030 Featuring Key Vendors - Caterpillar, Komatsu, Volvo, Hitachi, SANY, XCMG, JCB, Liebherr, Kobelco, and Zoomlion - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GCC Construction Equipment Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering. The GCC Construction Equipment Market was sized at 68,499 Units in 2024, and is projected to reach 94,499 Units by 2030, rising at a CAGR of 5.51%. Governments in the UAE and Saudi Arabia continue to prioritize urban growth and diversification, with Dubai's long-term 2040 Urban Master Plan and the Saudi Vision 2030-linked mega-projects fuelling o...
Back to Newsroom